Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Trulieve Cannabis Corp.

NYSE: TRLV · Life Sciences · 2 alerts · CIK 1754195

Share price
$10.33Close, Nov 16
Sector
Life Sciences
Industry
Medicinal Chemicals & Botanical ProductsSIC 2833

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Trulieve Cannabis Corp. filings on SEC EDGAR ↗

6:21 AM ET 10-Q
Financial Results

Trulieve Cannabis Q3 2026 Results: Turns Profitable, Net Income $774K

Trulieve reported a net loss of $403.0 million for the nine months ended September 30, 2026, primarily driven by a $403.3 million loss on a Deconsolidation Transaction. Revenue for the nine-month period decreased to $787.9 million from $888.0 million in the prior year, while cash and cash equivalents increased to $326.7 million.

Key figure
Net income $774K
6:16 AM ET 8-K
Financial Results

Trulieve Cannabis Financial Results

Trulieve Cannabis Corp. reported Q3 2026 revenue of $230 million and positive net income of $1 million, marking a significant period following its uplisting to the NYSE. The company highlighted major regulatory milestones, including receiving final DEA registrations for medical marijuana dispensaries and the removal of 280E tax burdens.

“State licensed medical marijuana rescheduling unlocked major milestones including DEA registration, removal of 280E tax, and uplisting to the NYSE. Third quarter results demonstrate the strength of our medical cannabis platform underscored by revenue, margins, and cash generation. With meaningful growth expansion opportunities in Georgia and Texas, we are in the early stages of an accelerated growth cycle.”

Kim Rivers, Trulieve CEO

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.